Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Graybug Vision, Inc. GRAY
$5.50
На 18:03, 12 мая 2023
-63.64%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
120983500.00000000
-
week52high
20.30
-
week52low
4.88
-
Revenue
2963000
-
P/E TTM
0
-
Beta
1.19917400
-
EPS
-20.63000000
-
Last Dividend
0.00000000
-
Next Earnings Date
08 мая 2023 г. в 20:05
Описание компании
Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the treatment of wet age-related macular degeneration, as well as in Phase IIa clinical trial to treat diabetic macular edema. It also develops GB-102, for the treatment of diabetic retinopathy; and GB-401, an intravitreally injected implant formulation of a beta-adrenergic receptor inhibitor to treat primary open-angle glaucoma. The company was formerly known as Graybug LLC and changed its name to Graybug Vision, Inc. in 2016. Graybug Vision, Inc. was incorporated in 2011 and is based in Redwood City, California.
Рекомендации
аналитиков
Рекомендации аналитиков
Grading company | New grade | Previous grade | Recommendation date |
---|---|---|---|
Piper Sandler | Neutral | Neutral | 19 мая 2022 г. |
Cantor Fitzgerald | Overweight | Overweight | 17 мар 2022 г. |
SVB Leerink | Market Perform | Outperform | 13 мая 2021 г. |
Needham | Hold | Buy | 13 мая 2021 г. |
Wedbush | Neutral | Outperform | 10 мар 2021 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
---|---|---|---|---|
BREUIL ROBERT S | D | 35000 | 5000 | 12 дек 2022 г. |
BREUIL ROBERT S | D | 87066 | 1729 | 12 дек 2022 г. |
BREUIL ROBERT S | A | 88795 | 5000 | 12 дек 2022 г. |
Guerard Frederic | D | 281250 | 28125 | 01 дек 2022 г. |
Guerard Frederic | D | 157530 | 11068 | 01 дек 2022 г. |
Guerard Frederic | A | 168598 | 28125 | 01 дек 2022 г. |
Zamiri Parisa | D | 93750 | 9375 | 01 дек 2022 г. |
Zamiri Parisa | D | 57577 | 2752 | 01 дек 2022 г. |
Zamiri Parisa | A | 60329 | 9375 | 01 дек 2022 г. |
BREUIL ROBERT S | D | 99375 | 9938 | 01 дек 2022 г. |
Новостная лента
Penny Stocks To Watch: Why REVB, RVPH, BARK, and GRAY Stock Are Moving
PennyStocks
09 авг 2022 г. в 14:11
Hot penny stocks to watch this week. The post Penny Stocks To Watch: Why REVB, RVPH, BARK, and GRAY Stock Are Moving appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Graybug to Present at the 2022 OIS Retina Innovation Summit
GlobeNewsWire
06 июл 2022 г. в 07:15
BALTIMORE, July 06, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of ocular diseases, today announced a platform presentation at the upcoming Ophthalmology Innovation Source (OIS) Retina Innovation Summit, to be held in New York City on July 13, 2022.
Graybug (GRAY) to Review Strategic Alternatives, Stock Up
Zacks Investment Research
29 июн 2022 г. в 13:55
Graybug's (GRAY) board of directors is set to review strategic options focused on maximizing shareholder value, including a potential sale of the company. Shares rise.
Graybug Vision (GRAY) Stock Soars 35% on Strategic Review News
InvestorPlace
28 июн 2022 г. в 15:07
Today, investors in Graybug Vision and GRAY stock are cheering an announced strategic review, which could see a sale of the company. The post Graybug Vision (GRAY) Stock Soars 35% on Strategic Review News appeared first on InvestorPlace.
Best Penny Stocks For July 2022? 5 To Watch Right Now
PennyStocks
28 июн 2022 г. в 12:30
Penny stocks to watch right now. The post Best Penny Stocks For July 2022?